Funding
The Epigenetic Etiology of Human Disease Lab at Mayo Clinic receives ongoing research support from several institutes of the National Institutes of Health.
Grants
| Investigator & Role |
Grant Title |
Funding Source |
Duration |
| Keith D. Robertson, Ph.D., principal investigator |
Epigenetic heterogeneity as a driver of liver disease and cancer (R01 AA27179) |
National Institute on Alcohol Abuse and Alcoholism |
08/16/2018-05/31/2023 |
| Keith D. Robertson, Ph.D., principal investigator |
Deciphering the interplay between H3K36 and DNA methylation in renal cancer (R01 CA224917) |
National Cancer Institute |
04/03/2018-03/31/2023 |
| Keith D. Robertson, Ph.D., principal investigator |
Epigenetic mechanisms underlying hepatitis C-induced hepatocarcinogenesis (R01 DK110024) |
National Institute of Diabetes and Digestive and Kidney Diseases |
09/01/2017-06/30/2021 |